GlassScriptPhysician profile
Andrew Lin Ko
NPI 1093817785
$7,956.39
in general payments reported to CMS, 2019-2025
11 companies · $2,167 in 2025
The $2,167 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,879 · 2020: $557 · 2021: $285 · 2022: $631 · 2023: $448 · 2024: $989 · 2025: $2,167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,511 · Travel and Lodging: $1,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,510.69 |
| Travel and Lodging | $1,093.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,112.95 | 2022-2025 | Activa PC, Percept PC Brainsense, Emprint |
| Medtronic USA, INC. | $2,780.03 | 2019-2020 | |
| Boston Scientific Corporation | $1,312.18 | 2019-2024 | Vercise |
| Nx Development Corp. | $318.45 | 2019-2020 | |
| Monteris Medical Corporation | $137.69 | 2025 | Neuroblate |
| Novocure INC. | $128.57 | 2020 | |
| Kls-Martin L.P. | $58.38 | 2025 | |
| Stryker Corporation | $46.28 | 2024 | Yukon Oct Spinal System, Capri Corpectomy Cage System |
| Biotronik Nro, INC. | $36.35 | 2025 | Prospera |
| Merck Sharp & Dohme LLC | $12.92 | 2022 | |
| Integra Lifesciences Corporation | $12.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Ko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.